APLS icon

Apellis Pharmaceuticals

95 hedge funds and large institutions have $423M invested in Apellis Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 33 increasing their positions, 25 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$23.6M
2 +$11.6M
3 +$9.31M
4
CAM
Cormorant Asset Management
Massachusetts
+$4.35M
5
O
OrbiMed
New York
+$4.31M

Top Sellers

1 -$29.4M
2 -$16M
3 -$6.6M
4
VC
Vivo Capital
California
-$6.33M
5
State Street
State Street
Massachusetts
-$3.95M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$59.4M
2
$49.2M
3
$29.4M
4
$28.6M
5
$27.7M
6
$23.6M
7
$19M
8
$18.3M
9
$15.6M
10
$14M
11
$11.5M
12
$10.1M
13
$9.48M
14
$9.31M
15
$7.74M
16
$7.42M
17
$6.96M
18
$6.59M
19
$6.2M
20
$5.75M
21
$5.56M
22
$4.71M
23
$4.31M
24
$3.91M
25
$3.63M